Method of inhibiting 5.alpha.-reductase with astaxanthin
US6277417A · kind A · utility
7Cited by
3References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 7, 2000 |
| Grant date | Aug 21, 2001 |
| Priority date | — |
| Expiry date | Apr 7, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for inhibiting the activity of the enzyme 5.alpha.-reductase in a human subject is provided which comprises administering to the subject a composition comprising the carotenoid astaxanthin. Administration of the composition to inhibit the enzyme is useful to prevent and treat benign prostate hyperplasia (BPH) and prostate cancer in human males.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.